About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Schulze Muscular Dystrophy Ability Clinical Study | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT05409079

Schulze Muscular Dystrophy Ability Clinical Study

The primary objective of the Schulze study is to evaluate the function of the upper limbs of subjects diagnosed with neuromuscular disorders, with and without use of the Abilitech Assist device in the...

Lead sponsor: AbiliTech Medical Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Chief Executive Officer

CONTACT

833.225.3123 info@abilitechmedical.com

Sponsors

Lead Sponsor

AbiliTech Medical Inc.

Collaborators

Richard M. Schulze Family Foundation

Age

10 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Subjects between 10 and 99 years of age, with onset of neuromuscular conditions that cause quadriparesis
•2. MMT score of 1-3 in the elbow, wrist and hand; and a MMT score of 2-3 in the shoulder of at least one of the subject's arms
•3. Ability of subject to raise their forearm off of their lap or laptray
•4. Willingness to comply and participate with the study protocol and attend the study sessions
•5. Ability to communicate verbally and respond to questions and commands
•6. Ability to provide informed consent
•7. Selected for participation based on investigator discretion

Exclusion Criteria

•1. Use of invasive ventilator
•2. Open wounds or chronic pressure sores on upper extremities, neck, back or torso
•3. Significantly unstable upper extremity joints
•4. Unhealed bone fractures in the upper extremities
•5. Active rotator cuff tear, grade 2 or 3
•6. Surgical fixations limiting full passive range of motion
•7. Uncontrolled upper-limb spasticity that significantly limits normal range of motion
•8. Uncontrollable pain in the neck, shoulders or upper limbs
•9. Ability to fully raise both hands simultaneously above their head with ease as defined by the investigator
•10. Lack passive shoulder abduction of 120 degrees
•11. Lack 90 degrees of passive elbow extension
•12. Unable to follow instructions
•13. Exhibit significant behavioral problems
•14. Inability to provide consent

Related studies

RECRUITINGPhase 1

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

NCT06817382 · Duchenne Muscular Dystrophy

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

NCT05866419 · Spinal Muscular Atrophy, Spine Deformity, and more

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

NCT06839469 · Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)

RECRUITINGPhase 1/2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

NCT07037862 · Duchenne Muscular Dystrophy (DMD)

Genetic and Physical Study of Childhood Nerve and Muscle Disorders

NCT01568658 · Muscular Dystrophies, Muscle Myopathies, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 5, 2022Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment35

Start dateMay 2022

Last updatedDec 5, 2022

Condition

Muscular Dystrophies Spinal Muscular Atrophy Duchenne Muscular Dystrophy Limb Girdle Muscular Dystrophy FSHD+2 more

Locations shown

Gillette Children's

Saint Paul, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 5, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions